Podcast thumbnail for Peptides Explained

Peptides Explained

Claim This Podcast

by John Garrett

5.0(1 reviews)
37 episodes
Updated Daily
Accepts GuestsHas Sponsors

Podcast Overview

Peptides Explained breaks down the most talked-about peptides and GLP-1 medications in health, fitness, and longevity — including semaglutide, tirzepatide, BPC-157, TB-500, and more. Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why they’re popular, what the research shows, and the real risks and side effects — all in plain language. No bro science. No hype. Just clear, foundational education. For informational purposes only. Not medical advice. For Research Peptides; Offlinepeptides.com/ref/johngarrett/ https://www.skool.com/peptides-explained-15

Language

🇺🇲

Publishing Since

2/22/2026

1 verified contact email on file for Peptides Explained

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for **Special Announcement** Healthcare Provider Webinar

July 31, 2026

**Special Announcement** Healthcare Provider Webinar

<p><strong>The State of Peptides 2026 | Clinician Webinar</strong></p><p>The peptide landscape is changing rapidly. New research is emerging, regulatory decisions continue to shape clinical practice, and healthcare providers are being asked more questions than ever before.</p><p>Join <strong>Peptide Solutions</strong> for a live clinician-focused webinar covering the current state of peptides in 2026. This educational session is designed for physicians, nurse practitioners, physician assistants, pharmacists, nurses, and other healthcare professionals interested in understanding the latest developments.</p><p>• The current peptide and GLP-1 landscape<br>• Recent FDA and PCAC regulatory updates<br>• The most commonly discussed therapeutic peptides<br>• Current evidence and clinical data<br>• Safety, quality, and sourcing considerations<br>• What providers should expect moving forward</p><p><strong>📅 August 13, 2026</strong><br><strong>🕖 7:00 PM Central Time</strong></p><p><strong>Register:</strong> <a href="https://peptide-solutions.info/">https://peptide-solutions.info</a></p><p>This webinar is intended for educational purposes only. Peptide Solutions does not diagnose, treat, prescribe, compound, or dispense medications. Prescription therapies require evaluation and oversight by a licensed healthcare provider. Discussions of research peptides are for educational purposes only and should not be interpreted as recommendations for human use.</p>

Episode thumbnail for The 11 Peptides I Find Most Compelling

July 29, 2026

The 11 Peptides I Find Most Compelling

<p>After researching peptide science week after week—and using some compounds personally—I’m answering one of the most common questions I receive: Which peptides do I find the most useful and compelling?</p><p>This is not a universal ranking or a recommendation to use all 11. Tirzepatide, retatrutide, tesamorelin, ipamorelin, BPC-157, TB-500, GHK-Cu, KPV, PT-141, MOTS-c, and SS-31 occupy very different evidence and regulatory categories. Some are FDA-approved prescription drugs. Some have encouraging human data. Others remain experimental and are supported mainly by animal, cell, mechanistic, or anecdotal evidence.</p><p>In this episode, we examine the problem each peptide is intended to solve, how it works, what the human evidence shows, where the evidence is weak, known risks, regulatory status, and why each compound made my personal list.</p><p>This episode is for education and discussion only. It is not medical advice. Always involve a qualified healthcare professional before starting, stopping, or changing a therapy.</p><p>Peptides Explained is an affiliate partner with OfflinePeptides.com. </p><p>Visit PeptidesExplained.info/OfflinePeptides.</p><p>For Peptides through a compounding pharmacy or a telehealth option </p><p>Visit Peptide-Solutions.info and submit a request for more information. </p>

Episode thumbnail for Cagrilintide vs GLP-1s: A Different Appetite Pathway?

July 27, 2026

Cagrilintide vs GLP-1s: A Different Appetite Pathway?

Host John Garrett interviews himself to explore how cagrilintide, an amylin analogue, offers a distinct approach to appetite regulation compared to GLP-1s, revealing its potential and current research findings.

37 total episodes available with 12 transcripts

Deep-dive analytics for Peptides Explained

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Peptides Explained?

Peptides Explained breaks down the most talked-about peptides and GLP-1 medications in health, fitness, and longevity — including semaglutide, tirzepatide, BPC-157, TB-500, and more.

Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why they’re popular, what the research shows, and the real risks and side effects — all in plain language.

No bro science. No hype. Just clear, foundational education.

For informational purposes only. Not medical advice.

For Research Peptides; Offlinepeptides.com/ref/johngarrett/ https://www.skool.com/peptides-explained-15

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

No, this podcast does not typically feature guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.